~ Buy the NEXPLANON (etonogestrel) Drug Profile, 2024 PDF Report in the Report Store ~

NEXPLANON Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Nexplanon, and when can generic versions of Nexplanon launch?

Nexplanon is a drug marketed by Organon and is included in one NDA. There are four patents protecting this drug.

This drug has one hundred and five patent family members in thirty-five countries.

The generic ingredient in NEXPLANON is etonogestrel. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the etonogestrel profile page.

DrugPatentWatch^® Generic Entry Outlook for Nexplanon

There has been one patent litigation case involving the patents protecting this drug, indicating strong interest in generic launch. Recent data indicate that 63% of patent challenges are decided in favor of the generic patent challenger and that 54% of successful patent challengers promptly launch generic drugs.

Indicators of Generic Entry

< Available with Subscription >

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for NEXPLANON?
What are the global sales for NEXPLANON?
What is Average Wholesale Price for NEXPLANON?

Summary for NEXPLANON

International Patents:	105
US Patents:	4
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	60
Clinical Trials:	29
Patent Applications:	2,000
Drug Prices:	Drug price information for NEXPLANON
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for NEXPLANON
What excipients (inactive ingredients) are in NEXPLANON?	NEXPLANON excipients list
DailyMed Link:	NEXPLANON at DailyMed

Drug patent expirations by year for NEXPLANON

Recent Clinical Trials for NEXPLANON

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Oregon Health and Science University	Early Phase 1
University of Saskatchewan	Phase 2
Saskatchewan Health Authority - Regina Area	Phase 2

See all NEXPLANON clinical trials

Pharmacology for NEXPLANON

Drug Class	Progestin

US Patents and Regulatory Information for NEXPLANON

NEXPLANON is protected by four US patents.

Patents protecting NEXPLANON

Kit for and method of assembling an applicator for inserting an implant
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

X-ray visible drug delivery device
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Applicator for inserting an implant
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Applicator for inserting an implant
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: PREVENTION OF PREGNANCY

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Organon	NEXPLANON	etonogestrel	IMPLANT;IMPLANTATION	021529-002	May 13, 2011		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Organon	NEXPLANON	etonogestrel	IMPLANT;IMPLANTATION	021529-002	May 13, 2011		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Organon	NEXPLANON	etonogestrel	IMPLANT;IMPLANTATION	021529-002	May 13, 2011		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Organon	NEXPLANON	etonogestrel	IMPLANT;IMPLANTATION	021529-002	May 13, 2011		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for NEXPLANON

See the table below for patents covering NEXPLANON around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Spain	2829626		⤷ Sign Up
Germany	602005007873		⤷ Sign Up
Portugal	1729819		⤷ Sign Up
South Korea	101241687		⤷ Sign Up
Netherlands	980027		⤷ Sign Up
Mexico	2007008880	APLICADOR PARA INSERTAR UN IMPLANTE. (APPLICATOR FOR INSERTING AN IMPLANT.)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for NEXPLANON

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0303306	C980027	Netherlands	⤷ Sign Up	PRODUCT NAME: ETONOGESTREL; REGISTRATION NO/DATE: RVG 21168 19980825
0303306	099C0041	Belgium	⤷ Sign Up	PRODUCT NAME: ETONOGESTREL; NATL. REGISTRATION NO/DATE: 52 IS 296 F 14 19990531; FIRST REGISTRATION: NL RVG 21168 19980825
0303306	SPC/GB99/044	United Kingdom	⤷ Sign Up	PRODUCT NAME: ETONOGESTREL; REGISTERED: NL RGV21168 19980825; UK 00065/0161 19990609
0303306	29/1999	Austria	⤷ Sign Up	PRODUCT NAME: ETONOGESTREL; NAT. REGISTRATION NO/DATE: 1-22964 19990330; FIRST REGISTRATION: NL 21168 19980825
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description